Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SENSORION-21685779/news/Sensorion-Announces-First-Patient-Enrolled-in-Proof-of-Concept-Clinical-Trial-of-SENS-401-for-Residu-41771102/?utm_source=whatsapp&utm_medium=social&utm_campaign=share